- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 303.93M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $134.23M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $150.92M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $47.31M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $46.34M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $115.94M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $81.84M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $468.76M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $472.66M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $273.74M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $268.31M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $410.14M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $393.84M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 324.73M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.41M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $6.7M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$229.97M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$246.17M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.04 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.04 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $22.33M |
| Net Income | Q1 2025 · Mar 31, 2024 | $10.63M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $16.72M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $3.82M |
| Revenue | Q1 2025 · Mar 31, 2024 | $66.26M |